Health Care • Medical/Dental Instruments
$41.98 ▼ -0.71
(-1.66%)
MKT CAP: $61.87B • VOL: 22.47M
52W L $40 52W H $106
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$35
MEDIAN
$47
MEAN
$48
HIGH
$57
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE BSX TAPE
BSX // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $50.80 | $48.28 | 2025-02-14 | $38.20 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $52.89 | $49.54 | 2025-02-06 | $39.46 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $47.86 | $46.18 | 2025-01-29 | $40.30 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $42.82 | — | 2025-01-17 | $41.14 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $36.94 | $39.88 | 2025-01-09 | $37.36 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $49.96 | $43.66 | 2024-12-18 | $36.52 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $40.72 | $42.40 | 2024-12-04 | $39.04 | -4.3% | 48% | C |